Shark-Derived Antibodies in Alzheimer’s Disease Therapy

Product News   Feb 06, 2017 | Original Story From Biolegend

 
Shark-Derived Antibodies in Alzheimer’s Disease Therapy

Biolegend

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Permanent Price Reduction on Synaptic Markers

Product News

In order to provide both economical and effective reagents for synapse studies, BioLegend is pleased to announce a permanent price reduction of up to 40% on over 70 synapse targets!

READ MORE

Purified Cancer Exosome Samples

Product News

AMSBIO has introduced a range of purified cancer exosome samples to help researchers study the role of exosomes in cancer development and metastasis.

READ MORE

Research into Degenerative Brain Disease Uses Qlucore Omics Explorer

Product News

Omics experimental methods are becoming critical in many areas of drug discovery, to allow the development of next generation, innovative therapeutics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE